$169.14
1.55% today
Nasdaq, Apr 02, 09:17 pm CET
ISIN
IE0005711209
Symbol
ICLR
Sector
Industry

ICON Plc Stock price

$166.56
-18.25 9.88% 1M
-117.95 41.46% 6M
-43.15 20.58% YTD
-165.17 49.79% 1Y
-80.07 32.47% 3Y
+34.36 25.99% 5Y
+96.00 136.04% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-8.43 4.82%
ISIN
IE0005711209
Symbol
ICLR
Sector
Industry

Key metrics

Market capitalization $13.45b
Enterprise Value $16.52b
P/E (TTM) P/E ratio 17.46
EV/FCF (TTM) EV/FCF 14.97
EV/Sales (TTM) EV/Sales 1.99
P/S ratio (TTM) P/S ratio 1.62
P/B ratio (TTM) P/B ratio 1.41
Revenue growth (TTM) Revenue growth 1.99%
Revenue (TTM) Revenue $8.28b
EBIT (operating result TTM) EBIT $1.22b
Free Cash Flow (TTM) Free Cash Flow $1.10b
Cash position $538.79m
EPS (TTM) EPS $9.54
P/E forward 14.94
P/S forward 1.61
EV/Sales forward 1.98
Short interest 2.01%
Show more

Is ICON Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

ICON Plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a ICON Plc forecast:

15x Buy
79%
4x Hold
21%

Analyst Opinions

19 Analysts have issued a ICON Plc forecast:

Buy
79%
Hold
21%

Financial data from ICON Plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
8,282 8,282
2% 2%
100%
- Direct Costs 6,334 6,334
0% 0%
76%
1,948 1,948
7% 7%
24%
- Selling and Administrative Expenses 140 140
0% 0%
2%
- Research and Development Expense - -
-
-
1,807 1,807
8% 8%
22%
- Depreciation and Amortization 588 588
6% 6%
7%
EBIT (Operating Income) EBIT 1,220 1,220
17% 17%
15%
Net Profit 791 791
29% 29%
10%

In millions USD.

Don't miss a Thing! We will send you all news about ICON Plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICON Plc Stock News

Neutral
PRNewsWire
about 4 hours ago
BENSALEM, Pa. , April 2, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Neutral
PRNewsWire
2 days ago
NEW YORK , March 31, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and October 23, 2024, both dates inclusive (the "Class Period"), of the important April 11, 2025 lead plaintiff deadline. So what: If you purchased ICON ordinary shares during the Class Period you may be entitled to c...
Neutral
Business Wire
2 days ago
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules First Quarter 2025 Earnings Conference Call.
More ICON Plc News

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Stephen Cutler
Employees 41,900
Founded 1989
Website www.iconplc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today